Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Minor update to the Study Record dates/text; core study content such as eligibility criteria, endpoints, and treatment arms remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:21:34.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:49:10.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Page now adds extensive immune-related terminology and a version upgrade to v3.1.0; the previous v3.0.2 revision is removed.
    Difference
    0.7%
    Check dated 2025-09-29T03:09:03.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page now shows Revision v3.0.2 and new September 2025 dates, while older dates and the previous Revision v3.0.1 have been removed.
    Difference
    0.3%
    Check dated 2025-09-14T19:20:04.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, v3.0.1, indicating a recent revision. The previous update information has been removed.
    Difference
    0.1%
    Check dated 2025-09-07T15:58:10.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location details, along with a range of medical and diagnostic techniques, while removing outdated location information and certain medical terms.
    Difference
    2%
    Check dated 2025-08-31T11:56:27.000Z thumbnail image

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.